Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
NASDAQ:JYNT
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
<0.01Last Year’s EPS
0.06Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 13, 2025
|% Change Since: 18.50%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in new patient growth and revenue increases, alongside strategic progress in refranchising efforts. However, challenges such as decreased franchise license sales, economic headwinds, and the transitional financial impact of refranchising were noted. While the company is making strides towards profitability and growth, it is facing some economic and operational challenges.Company Guidance
During The Joint Corp.'s fourth-quarter and year-end 2024 financial results conference call, several key metrics and guidance for 2025 were highlighted. In 2024, the company achieved system-wide sales of $530.3 million, with a 9% increase in Q4 compared to Q3. Revenue from continuing operations rose by 14% in Q4 2024, and consolidated adjusted EBITDA was $3.3 million for the quarter and $11.4 million for the year. For 2025, The Joint Corp. expects system-wide sales to reach between $550 and $570 million, with mid-single-digit growth in system-wide comp sales for clinics open for more than thirteen months. Additionally, new franchise clinic openings are projected to be between 30 and 40, excluding the impact of refranchised clinics. The company plans to transition its corporate-owned clinics to a franchised model, which will shift revenue streams from corporate clinic revenues to royalties and fees, leading to a more profitable structure as unallocated G&A expenses are rationalized.Strong New Patient Growth
The Joint Corp. served 950,000 new patients in 2024, demonstrating significant reach and impact in the chiropractic care market.
Record System-Wide Sales
For 2024, system-wide sales increased to $530.3 million, with a 9% increase in Q4 2024 compared to 8% in Q3 2024.
Revenue Growth
Revenue for continuing operations increased 14% in Q4 2024, up from 10% in Q3 2024.
Improved Patient Engagement
System-wide comp sales for mature clinics opened forty-eight months were modestly positive for Q4 2024, compared to negative 2% in Q3 2024.
Refranchising Progress
The company has made significant strides in its refranchising efforts, with the vast majority of corporate clinics under letters of intent for sale.
---
JYNT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
JYNT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 13, 2025 | $10.54 | $11.02 | +4.55% |
| Nov 07, 2024 | $11.88 | $11.61 | -2.27% |
| Aug 08, 2024 | $12.33 | $11.30 | -8.35% |
| May 02, 2024 | $12.86 | $16.12 | +25.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Joint Corp (JYNT) report earnings?
Joint Corp (JYNT) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Joint Corp (JYNT) earnings time?
Joint Corp (JYNT) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is JYNT EPS forecast?
JYNT EPS forecast for the fiscal quarter 2025 (Q1) is <0.01.
---